跳轉至內容
Merck
全部照片(1)

Key Documents

N0290

Sigma-Aldrich

硝唑尼特

≥98% (HPLC)

同義詞:

NTZ; 2-乙酸基-N-(5-硝基-2-噻唑基)苯甲酰胺

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C12H9N3O5S
CAS號碼:
分子量::
307.28
EC號碼:
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

化驗

≥98% (HPLC)

形狀

powder

起源

Romark

儲存溫度

2-8°C

SMILES 字串

CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+]([O-])=O

InChI

1S/C12H9N3O5S/c1-7(16)20-9-5-3-2-4-8(9)11(17)14-12-13-6-10(21-12)15(18)19/h2-6H,1H3,(H,13,14,17)

InChI 密鑰

YQNQNVDNTFHQSW-UHFFFAOYSA-N

尋找類似的產品? 前往 產品比較指南

一般說明

硝唑尼特(NTZ)是一种噻唑化物类(thiazolide)化合物,它是一种结构与氯硝柳胺相似的抗寄生虫药。

應用

硝唑尼特已被用于:
  • 测试其对基孔肯雅病毒的抗病毒活性
  • 作为抗原生动物剂用于测试其对多种癌细胞系细胞活力的影响
  • 测试其对感染人巨细胞病毒(HCMV)的人成纤维细胞HFF细胞的影响

生化/生理作用

硝唑尼特是丙酮酸-铁氧还蛋白氧化还原酶(PFOR)抑制剂,FDA批准的抗寄生虫药(2002)。近期研究(C & EN Sept. 14, 2009, p. 28)表明,硝唑尼特可杀死非复制和复制的结核菌,未检测到明显的耐药性。
硝唑尼特(NTZ)通过作用于激酶信号传导通路来促进自噬,并作用于分枝杆菌中雷帕霉素复合物1(mTORC1)的哺乳动物靶点。体外研究中,它具有抗病毒特性,并有效地阻止了基孔肯雅病毒的进入和释放。NTZ还可以抑制早期阶段的日本脑炎病毒(JEV)感染,并具有治疗其他病毒感染的潜力,包括登革热、乙型肝炎(HBV)、冠状病毒和人类免疫缺陷病毒(HIV)。它具有抗恶性肿瘤功能,并可通过促进原癌基因c-Myc抑制来诱导细胞凋亡,从而导致肿瘤抑制。

特點和優勢

该化合物由 Romark 开发。要浏览其他制药公司开发的化合物列表批准的药物/候选药物的列表, 点击这里

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Benjamin Speich et al.
Parasites & vectors, 6, 3-3 (2013-01-08)
Pathogenic intestinal protozoa infections are common in school-aged children in the developing world and they are frequently associated with malabsorption syndromes and gastrointestinal morbidity. Since diagnosis of these parasites is difficult, prevalence data on intestinal protozoa is scarce. We collected
Jean-François Rossignol et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 106(3), 167-173 (2012-02-04)
We conducted a double-blind, placebo-controlled clinical trial to demonstrate the efficacy of nitazoxanide suspension for the treatment of presumed infectious diarrhea in children. Eligible patients must have had diarrheal illness lasting 3-29 days. Patients were randomized to receive either nitazoxanide
Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis
Lam KYK
PLoS Pathogens, 8(5), 340-351 (2012)
Irit Krause et al.
The Pediatric infectious disease journal, 31(11), 1135-1138 (2012-07-20)
Cryptosporidium parvum is a common cause of diarrhea. In immunocompetent individuals, spontaneous recovery is the rule. In immunocompromised patients, it may cause a serious disease. Data on cryptosporidiosis in children after solid organ transplantation are few. We report on 6
Vanessa R Anderson et al.
Drugs, 67(13), 1947-1967 (2007-08-29)
Nitazoxanide (Alinia, Daxon, Dexidex, Paramix, Kidonax, Colufase, Annita) has in vitro activity against a variety of microorganisms, including a broad range of protozoa and helminths. Nitazoxanide is effective in the treatment of protozoal and helminthic infections, including Cryptosporidium parvum or

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務